A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

A study published in the journal Stem Cells Reports reveals that a cellular reprogramming methodology allows the creation of neural networks that reproduce unique characteristics of human ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Human-induced pluripotent stem cells (hiPSCs) can differentiate into various tissues, an invaluable characteristic for personalized regenerative medicine, basic and translational research, and drug ...

In part, this is due to the difficulty in recreating adequate animal or cellular models. By reprogramming skin cells into neurons, Johan Jakobsson and his research group have been able to study ...

Human skin cells have been reprogrammed into heart valve cells and then used to successfully transplant a pig heart valve into a rodent, led by the research of a Northeastern University professor. The ...